Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approves Quidel's osteoporosis device:

This article was originally published in Clinica

Executive Summary

The US FDA has approved Quidel's portable ultrasound device for helping to diagnose osteoporosis. The QUS-2, a self-contained, battery operated device, assesses the density of bone in the heel and provides quantitative results. It uses a dry scanning technology that precisely locates an optimal measurement site within the heel, said San Diego, California-based Quidel. The company added that the device's ability to discriminate fracture status was similar to that of X-ray bone density techniques of the spine and hip.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076874

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel